tert-butyl (2S,4S)-4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate

Catalog No.: 
ACHPQL307
CAS No.: 
1808584-62-4
Molecular Formula: 
C12H23NO3
Molecular Weight: 
229.32
tert-butyl (2S,4S)-4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$294.00InquiryInquiry
250mg97%$469.00InquiryInquiry
500mg97%$781.00InquiryInquiry
1g97%$1170.00InquiryInquiry
5g97%$3510.00InquiryInquiry
10g97%$5968.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (2S,4S)-4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate
IUPAC Nametert-butyl (2S,4S)-4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate
MDL No.0
Molecular FormulaC12H23NO3
Molecular Weight229.32
SMILESC[C@H]1C[C@@H](CO)CCN1C(=O)OC(C)(C)C
InChI KeyLXOVPEAYTWFSBI-UWVGGRQHSA-N
Synonym1807941-59-8 | CS-0078545 | E77444 | 1808584-62-4 | EN300-214764 | tert-butyl 4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate, cis | MFCD31743361 | PS-19570 | tert-butyl (2S,4S)-4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate | (2S,4S)-tert-Butyl 4-
CAS No.1808584-62-4
PubChem CID99645458

Synthetic Route by SureRoute

1. ACHPQL307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPXBY735 route compound structure diagram
    ACPXBY7351820583-83-2In Stock
  2. Then
  3. ACHPQL307 route product structure diagram
    ACHPQL3071808584-62-4
Inquiry

2. ACHPQL307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHPQL307 route product structure diagram
    ACHPQL3071808584-62-4
Inquiry

3. ACHPQL307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHPQL307 route product structure diagram
    ACHPQL3071808584-62-4
Inquiry

Comments (0)